Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma
Author:
Funder
POETIC Foundation
CorMedix Inc.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10637-019-00816-1.pdf
Reference42 articles.
1. Moreno L, Caron H, Geoerger B, Eggert A, Schleiermacher G, Brock P, Valteau-Couanet D, Chesler L, Schulte JH, De Preter K, Molenaar J, Schramm A, Eilers M, Van Maerken T, Johnsen JI, Garrett M, George SL, Tweddle DA, Kogner P, Berthold F, Koster J, Barone G, Tucker ER, Marshall L, Herold R, Sterba J, Norga K, Vassal G, Pearson AD (2017) Accelerating drug development for neuroblastoma - new drug development strategy: an innovative therapies for children with Cancer, European network for Cancer research in children and adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. Expert Opin Drug Discovery 12(8):801–811. https://doi.org/10.1080/17460441.2017.1340269
2. Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KK, Hogarty M (2013) Children's oncology Group's 2013 blueprint for research: neuroblastoma. Pediatr Blood Cancer 60(6):985–993. https://doi.org/10.1002/pbc.24433
3. Jacobi CA, Menenakos C, Braumann C (2005) Taurolidine--a new drug with anti-tumor and anti-angiogenic effects. Anti-Cancer Drugs 16(9):917–921
4. Redmond HP, Neary PM, Jinih M, O'Connell E, Foley N, Pfirrmann RW, Wang JH, O'Leary DP (2018) RandomiSed clinical trial assessing use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.a.N.T. trial. BMC Cancer 18(1):794. https://doi.org/10.1186/s12885-018-4641-x
5. Winnicki W, Herkner H, Lorenz M, Handisurya A, Kikić Ž, Bielesz B, Schairer B, Reiter T, Eskandary F, Sunder-Plassmann G, Sengoelge G (2018) Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney Int 93(3):753–760. https://doi.org/10.1016/j.kint.2017.06.026
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis;American Journal of Therapeutics;2024-05-07
2. Photosensitized 1,2-Difunctionalization of Alkenes to Access β-Amino Sulfonamides;Organic Letters;2024-03-05
3. Exploring the effects of taurolidine on tumor weight and microvessel density in a murine model of osteosarcoma;Oncology Research;2024
4. Use of taurolidine in the prevention and treatment of catheter infections;Klinická farmakologie a farmacie;2022-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3